MLSC's Women's Health Initiative Provides Over $6.5 million for Pregnancy-Induced Hypertension and Perimenopause/Menopause Research July 29, 2026
IMUNON Announces New Immunogenicity Data from Phase 1 Clinical Trial of Its DNA Vaccine in Treatment of COVID-19 February 26, 2025
